Effects of bone marrow mesenchymal stromal cells on gross motor function measure scores of children with cerebral palsy: a preliminary clinical study

Bax, 2005, Proposed definition and classification of cerebral palsy, April 2005, Dev Med Child Neurol, 47, 571, 10.1017/S001216220500112X Andersen, 2011, Cerebral palsy among children born moderately preterm or at moderately low birthweight between 1980 and 1998: a European register-based study, Dev Med Child Neurol, 53, 913, 10.1111/j.1469-8749.2011.04079.x Cansu, 2006, Prevalence of cerebral palsy in Turkish children between the ages of 2 and 16 years, Dev Med Child Neurol, 48, 413, 10.1017/S0012162206000910 Boyd, 2010, INCITE: a randomised trial comparing constraint induced movement therapy and bimanual training in children with congenital hemiplegia, BMC Neurol, 10, 4, 10.1186/1471-2377-10-4 Wallen, 2011, Modified constraint-induced therapy for children with hemiplegic cerebral palsy: a randomized trial, Dev Med Child Neurol, 53, 1091, 10.1111/j.1469-8749.2011.04086.x Rostami, 2012, Effect of treatment environment on modified constraint-induced movement therapy results in children with spastic hemiplegic cerebral palsy: a randomized controlled trial, Disabil Rehabil, 34, 40, 10.3109/09638288.2011.585214 Willoughby, 2009, Systematic review of the effectiveness of treadmill training for children with cerebral palsy, Disabil Rehabil, 31, 1971, 10.3109/09638280902874204 Van Den Broeck, 2010, The effect of individually defined physiotherapy in children with cerebral palsy (CP), Eur J Paediatr Neurol, 14, 519, 10.1016/j.ejpn.2010.03.004 Meirelles Lda, 2009, Mechanisms involved in the therapeutic properties of mesenchymal stem cells, Cytokine Growth Factor Rev, 20, 419, 10.1016/j.cytogfr.2009.10.002 Teixeira FG, Carvalho MM, Sousa N, Salgado AJ. Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration? Cell Mol Life Sci. 2013 Mar 1. [Epub ahead of print]. Engela, 2012, On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation, Front Immunol, 3, 126, 10.3389/fimmu.2012.00126 Kassis, 2011, Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotection, Curr Stem Cell Res Ther, 6, 63, 10.2174/157488811794480762 Caplan, 2009, Why are MSCs therapeutic? New data: new insight, J Pathol, 217, 318, 10.1002/path.2469 Huang, 2013, Transplantation of differentiated bone marrow stromal cells promotes motor functional recovery in rats with stroke, Neurol Res, 35, 320, 10.1179/1743132812Y.0000000151 Bakhtiary, 2010, Comparison of transplantation of bone marrow stromal cells (BMSC) and stem cell mobilization by granulocyte colony stimulating factor after traumatic brain injury in rat, Iran Biomed J, 14, 142 Zhang, 2008, A combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injury, Cytotherapy, 10, 134, 10.1080/14653240701883061 Quertainmont, 2012, Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions, PLoS One, 7, e39500, 10.1371/journal.pone.0039500 Cho, 2009, Functional recovery after the transplantation of neurally differentiated mesenchymal stem cells derived from bone marrow in a rat model of spinal cord injury, Cell Transplant, 18, 1359, 10.3727/096368909X475329 Maltman, 2011, Role of mesenchymal stem cells in neurogenesis and nervous system repair, Neurochem Int, 59, 347 Li, 2011, Regulatory factors of mesenchymal stem cell migration into injured tissues and their signal transduction mechanisms, Front Med, 5, 33, 10.1007/s11684-011-0114-1 Pourrajab, 2013, Molecular characteristics of bone marrow mesenchymal stem cells, source of regenerative medicine, Int J Cardiol, 163, 125, 10.1016/j.ijcard.2011.11.017 Azari, 2010, Mesenchymal stem cells for treatment of CNS injury, Curr Neuropharmacol, 8, 316, 10.2174/157015910793358204 Feng, 2011, Serial 18F-FDG PET demonstrates benefit of human mesenchymal stem cells in treatment of intracerebral hematoma: a translational study in a primate model, J Nucl Med, 52, 90, 10.2967/jnumed.110.080325 Lindvall, 2006, Stem cells for the treatment of neurological diseases, Nature, 414, 1094, 10.1038/nature04960 Ribeiro, 2011, The secretome of bone marrow mesenchymal stem cells-conditioned media varies with time and drives a distinct effect on mature neurons and glial cells (primary cultures), J Tissue Eng Regen Med, 5, 668, 10.1002/term.365 Wakitani, 2011, Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months, J Tissue Eng Regen Med, 5, 146, 10.1002/term.299 Dimitriou, 2008, Properties and potential of bone marrow mesenchymal stromal cells from children with hematologic diseases, Cytotherapy, 10, 125, 10.1080/14653240701851332 Russell, 2010, Using knowledge brokers to facilitate the uptake of pediatric measurement tools into clinical practice: a before-after intervention study, Implement Sci, 23, 92, 10.1186/1748-5908-5-92 Russell, 2010, Development and validation of item sets to improve efficiency of administration of the 66-item Gross Motor Function Measure in children with cerebral palsy, Dev Med Child Neurol, 52, e48, 10.1111/j.1469-8749.2009.03481.x Rosenbaum, 2002, Prognosis for gross motor function in cerebral palsy: creation of motor development curves, JAMA, 288, 1357, 10.1001/jama.288.11.1357 Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, 8, 315, 10.1080/14653240600855905 Hanna, 2008, Reference curves for the Gross Motor Function Measure: percentiles for clinical description and tracking over time among children with cerebral palsy, Phys Ther, 88, 1, 10.2522/ptj.20070314 van Velthoven, 2010, Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function, J Neurosci, 30, 9603, 10.1523/JNEUROSCI.1835-10.2010 van Velthoven, 2010, Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration, Brain Behav Immun, 24, 387, 10.1016/j.bbi.2009.10.017 Yoo, 2008, Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model, Exp Mol Med, 40, 387, 10.3858/emm.2008.40.4.387 Dharmasaroja, 2009, Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke, J Clin Neurosci, 16, 12, 10.1016/j.jocn.2008.05.006 Lee, 2010, Neural stem cells: properties and therapeutic potentials for hypoxic-ischemic brain injury in newborn infants, Pediatr Int, 52, 855, 10.1111/j.1442-200X.2010.03266.x Gaspard, 2011, From stem cells to neural networks: recent advances and perspectives for neurodevelopmental disorders, Dev Med Child Neurol, 53, 13, 10.1111/j.1469-8749.2010.03827.x Lee, 2010, A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke, Stem Cells, 28, 1099, 10.1002/stem.430 Wang, 2010, Effects of bone marrow mesenchymal stem cell graft on gross motor function in children with cerebral palsy, J China-Japan Friendship Hospital, 24, 337